Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases

被引：6
|
作者：
Jiang, Tao [1 ,2 ]
Xu, Xiaobo [2 ]
Chen, Xiaojuan [3 ]
Ding, Ning [2 ]
Hu, Qin [4 ]
Zhou, Caicun [1 ]
Hu, Jie [2 ]
机构：
[1] Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai Resp Res Inst, 180 Fenglin Rd, Shanghai 200032, Peoples R China
[3] Wenzhou Med Univ, Dept Gastroenterol, Wenzhou Clin Inst 3, Wenzhou Peoples Hosp, Wenzhou, Peoples R China
[4] Fudan Univ, Shanghai Resp Res Inst, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2020年 / 9卷 / 06期
基金：
中国国家自然科学基金;
关键词：
CELL LUNG-CANCER; ERLOTINIB; SURVIVAL;
D O I：
10.21037/tlcr-20-984
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2514 / 2517
页数：4
相关论文
共 50 条
  • [31] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Tsuboi, Masahiro
    Herbst, Roy S.
    John, Thomas
    Kato, Terufumi
    Majem, Margarita
    Grohe, Christian
    Wang, Jie
    Goldman, Jonathan W.
    Lu, Shun
    de Marinis, Filippo
    Shepherd, Frances A.
    Lee, Ki Hyeong
    Le, Nhieu Thi
    Dechaphunkul, Arunee
    Kowalski, Dariusz
    Bonanno, Laura
    Domine, Manuel
    Poole, Lynne
    Bolanos, Ana
    Rukazenkov, Yuri
    Wu, Yi-Long
    TARGETED ONCOLOGY, 2024, 19 (02) : 131 - 134
  • [32] Osimertinib in Stage III EGFR-Mutated NSCLC - Game, Set, Match
    Leighl, Natasha B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (07): : 652 - 654
  • [33] Efficacy of dacomitinib in patients with EGFR-mutated NSCLC and brain metastases
    Zhang, Jinyao
    Wang, Yan
    Liu, Ziling
    Wang, Lin
    Yao, Yu
    Liu, Yutao
    Hao, Xue Zhi
    Wang, Jianyang
    Xing, Puyuan
    Li, Junling
    THORACIC CANCER, 2021, 12 (24) : 3407 - 3415
  • [34] EGFR amplification indicated poor prognosis in EGFR-mutated lung cancer with leptomeningeal metastases
    Geng, Di
    Niu, Ruina
    Li, Jinghong
    Guo, Sanxing
    Guo, Qianqian
    Huang, Siyuan
    Wang, Yurong
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (02):
  • [35] A Study of Aumolertinib Monotherapy or Combination Treated EGFR-mutated NSCLC Patients with Symptomatic Brain Metastases
    Zhang, X.
    Zhang, M.
    Du, X.
    Zhang, G.
    Niu, Y.
    Wei, C.
    Guo, L.
    Shi, C.
    Wang, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S660 - S660
  • [36] Treatment Strategies and Survival Outcomes of Patients with EGFR-mutated NSCLC and leptomeningeal metastasis
    Fan, Y.
    Wu, H.
    Chen, K.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S652 - S652
  • [37] Erlotinib and bevacizumab combination therapy for afatinib-refractory leptomeningeal carcinomatosis from EGFR-mutated lung cancer
    Miyuki Abe
    Atsushi Osoegawa
    Takashi Karashima
    Yohei Takumi
    Ryoji Kobayashi
    Takafumi Hashimoto
    Michiyo Miyawaki
    Hideya Takeuchi
    Tatsuro Okamoto
    Kenji Sugio
    International Cancer Conference Journal, 2019, 8 : 81 - 85
  • [38] Erlotinib and bevacizumab combination therapy for afatinib-refractory leptomeningeal carcinomatosis from EGFR-mutated lung cancer
    Abe, Miyuki
    Osoegawa, Atsushi
    Karashima, Takashi
    Takumi, Yohei
    Kobayashi, Ryoji
    Hashimoto, Takafumi
    Miyawaki, Michiyo
    Takeuchi, Hideya
    Okamoto, Tatsuro
    Sugio, Kenji
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2019, 8 (02) : 81 - 85
  • [39] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
    Saboundji, Karima
    Auliac, Jean-Bernard
    Perol, Maurice
    Francois, Geraldine
    Janicot, Henri
    Marcq, Marie
    Dubos-Arvis, Catherine
    Renault, Aldo
    Guisier, Florian
    Odier, Luc
    Gervais, Radj
    Chouaid, Christos
    TARGETED ONCOLOGY, 2018, 13 (04) : 501 - 507
  • [40] Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors
    Karima Saboundji
    Jean-Bernard Auliac
    Maurice Pérol
    Géraldine François
    Henri Janicot
    Marie Marcq
    Catherine Dubos-Arvis
    Aldo Renault
    Florian Guisier
    Luc Odier
    Radj Gervais
    Christos Chouaïd
    Targeted Oncology, 2018, 13 : 501 - 507
12345